Literature DB >> 18509172

Reversal of drug resistance in ovarian cancer: where do we go from here?

Stan B Kaye.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18509172     DOI： 10.1200/JCO.2008.16.2123

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  22 in total

1.  ATP-binding cassette transporters modulate both coelenterazine- and D-luciferin-based bioluminescence imaging.

Authors:  Ruimin Huang; Jelena Vider; Inna Serganova; Ronald G Blasberg
Journal:  Mol Imaging       Date:  2011-06       Impact factor: 4.488

Review 2.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Combination of a MDR1-targeted replicative adenovirus and chemotherapy for the therapy of pretreated ovarian cancer.

Authors:  Daniel T Rein; Anne Volkmer; Gerd Bauerschmitz; Ines M Beyer; Wolfgang Janni; Markus C Fleisch; Anne Kathrin Welter; Dirk Bauerschlag; Thomas Schöndorf; Martina Breidenbach
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-01       Impact factor: 4.553

4.  Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot study.

Authors:  Eisuke Kobayashi; Arun K Iyer; Francis J Hornicek; Mansoor M Amiji; Zhenfeng Duan
Journal:  Clin Orthop Relat Res       Date:  2013-03       Impact factor: 4.176

5.  P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia.

Authors:  Gwen McCaffrey; William D Staatz; Lucy Sanchez-Covarrubias; Jessica D Finch; Kristen Demarco; Mei-Li Laracuente; Patrick T Ronaldson; Thomas P Davis
Journal:  J Neurochem       Date:  2012-07-10       Impact factor: 5.372

6.  Proteomics Analysis of Ovarian Cancer Cell Lines and Tissues Reveals Drug Resistance-associated Proteins.

Authors:  Isa N Cruz; Helen M Coley; Holger B Kramer; Thumuluru Kavitah Madhuri; Nur A M Safuwan; Ana Rita Angelino; Min Yang
Journal:  Cancer Genomics Proteomics       Date:  2017-01-02       Impact factor: 4.069

7.  Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas.

Authors:  Stefanie M Ueda; Kai Lee Yap; Ben Davidson; Yuan Tian; Vivek Murthy; Tian-Li Wang; Kala Visvanathan; Francis P Kuhajda; Robert E Bristow; Hui Zhang; Ie-Ming Shih
Journal:  J Oncol       Date:  2010-05-19       Impact factor: 4.375

8.  Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.

Authors:  Michiro Susa; Arun K Iyer; Keinosuke Ryu; Edwin Choy; Francis J Hornicek; Henry Mankin; Lara Milane; Mansoor M Amiji; Zhenfeng Duan
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240

9.  NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance.

Authors:  Zhenfeng Duan; Edwin Choy; Francis J Hornicek
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

10.  Potential predictive markers of chemotherapy resistance in stage III ovarian serous carcinomas.

Authors:  Lovisa Osterberg; Kristina Levan; Karolina Partheen; Ulla Delle; Björn Olsson; Karin Sundfeldt; György Horvath
Journal:  BMC Cancer       Date:  2009-10-18       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.